Asymptomatic COVID-19 cases among older patients despite BNT162b2 vaccination: A case series in a geriatric rehabilitation ward during an outbreak.
作者信息
Donadio Cristiano, Rainone Antonio, Gouronnec Adéline, Belmin Joël, Lafuente-Lafuente Carmelo
机构信息
Service de gériatrie à orientation cardiologique et neurologique, AP-HP, Sorbonne Universite, Hopitaux universitaires Pitie-Salpetriere-Charles Foix, Ivry-sur-Seine 94205, France.
Service de Soins de Suite et de Readaptation Geriatrique, AP-HP, Sorbonne Universite, Hopitaux universitaires Pitie-Salpetriere-Charles Foi, Ivry-sur-Seine 94205, France.
出版信息
J Infect. 2021 Jul;83(1):119-145. doi: 10.1016/j.jinf.2021.04.004. Epub 2021 Apr 11.
Abstract
摘要
相似文献
1
Asymptomatic COVID-19 cases among older patients despite BNT162b2 vaccination: A case series in a geriatric rehabilitation ward during an outbreak.老年患者接种BNT162b2疫苗后仍出现无症状新冠病毒感染病例：疫情期间老年康复病房的病例系列
J Infect. 2021 Jul;83(1):119-145. doi: 10.1016/j.jinf.2021.04.004. Epub 2021 Apr 11.
2
Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.医护人员对辉瑞BNT162b2 mRNA新冠疫苗的总体体液反应的三个月分析
J Infect. 2021 Aug;83(2):e4-e5. doi: 10.1016/j.jinf.2021.06.024. Epub 2021 Jun 30.
3
Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution.血清阳性医护人员完成 BNT162b2 全程接种后出现有症状的 SARS-CoV-2 感染：来自单一机构的病例系列研究。
Emerg Microbes Infect. 2021 Dec;10(1):1254-1256. doi: 10.1080/22221751.2021.1942230.
4
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).肾移植受者对 BNT162b2（辉瑞-生物科技）接种 SARS-CoV-2 疫苗的体液免疫反应受损。
Viruses. 2021 Apr 25;13(5):756. doi: 10.3390/v13050756.
5
Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won.首次接种BNT162b2 mRNA新冠疫苗后透析患者体内中和新型冠状病毒2抗体的反应：这场战斗远未胜利。
Kidney Int. 2021 Jun;99(6):1494-1496. doi: 10.1016/j.kint.2021.04.010. Epub 2021 Apr 20.
6
High anaphylaxis rates following vaccination with the Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers: a secondary analysis of initial post-approval safety data.日本医护人员接种辉瑞BNT162b2新冠mRNA疫苗后过敏反应发生率较高：批准后初始安全性数据的二次分析
J Travel Med. 2021 Oct 11;28(7). doi: 10.1093/jtm/taab090.
7
A Series of Patients With Myocarditis Following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2.一系列接种mRNA-1279和BNT162b2新冠疫苗后发生心肌炎的患者。
JACC Cardiovasc Imaging. 2021 Sep;14(9):1862-1863. doi: 10.1016/j.jcmg.2021.06.003. Epub 2021 Jun 16.
8
Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine.接种BNT162b2 mRNA疫苗后，医护人员和八旬老人针对新冠病毒的年龄和性别依赖性抗体反应。
Am J Hematol. 2021 Jul 1;96(7):E257-E259. doi: 10.1002/ajh.26185. Epub 2021 Apr 24.
9
Effect of SARS-CoV-2 vaccination among health care workers in a geriatric care unit after a B.1.1.7-variant outbreak.在B.1.1.7变异株爆发后，老年护理病房医护人员接种新冠病毒疫苗的效果。
Public Health. 2021 Sep;198:e20-e22. doi: 10.1016/j.puhe.2021.06.003. Epub 2021 Jun 19.
10
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.BNT162b2信使核糖核酸新冠疫苗在全国大规模疫苗接种中的应用情况
N Engl J Med. 2021 May 20;384(20):1968-1970. doi: 10.1056/NEJMc2104281. Epub 2021 Apr 21.
引用本文的文献
1
Nosocomial Transmission of SARS-CoV-2 Involving Vaccinated Health Care Workers.医疗机构中涉及接种疫苗的医护人员的 SARS-CoV-2 传播。
Microbiol Spectr. 2022 Feb 23;10(1):e0153221. doi: 10.1128/spectrum.01532-21. Epub 2022 Jan 5.
2
Clinical Phenotype and Contagiousness of Early Breakthrough SARS-CoV-2 Infections after BNT162b2 COVID-19 mRNA Vaccine: A Parallel Cohort Study in Healthcare Workers.BNT162b2新冠mRNA疫苗接种后早期突破性SARS-CoV-2感染的临床表型及传染性：一项针对医护人员的平行队列研究
Vaccines (Basel). 2021 Nov 23;9(12):1377. doi: 10.3390/vaccines9121377.
3
Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.接种 COVID-19 mRNA 疫苗后，需要数天才能诱导针对 SARS-CoV-2 的高特异性体液和细胞反应。
Front Immunol. 2021 Oct 4;12:726960. doi: 10.3389/fimmu.2021.726960. eCollection 2021.
4
Nationwide Seroprevalence of SARS-CoV-2 IgG Antibodies among Four Groups of Primary Health-Care Workers and Their Household Contacts 6 Months after the Initiation of the COVID-19 Vaccination Campaign in France: SeroPRIM Study Protocol.法国开展新冠疫苗接种运动6个月后，四组初级卫生保健工作者及其家庭接触者中SARS-CoV-2 IgG抗体的全国血清流行率：SeroPRIM研究方案
Pathogens. 2021 Jul 20;10(7):911. doi: 10.3390/pathogens10070911.
本文引用的文献
1
The challenge of asymptomatic SARS-CoV-2 transmission in care homes.养老院中无症状新冠病毒传播的挑战。
Lancet Reg Health Eur. 2021 Apr;3:100051. doi: 10.1016/j.lanepe.2021.100051. Epub 2021 Feb 25.
2
Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers.血清阴性和血清阳性医护人员接种一剂和两剂mRNA-1273后的反应原性、安全性及抗体反应。
J Infect. 2021 Aug;83(2):237-279. doi: 10.1016/j.jinf.2021.03.025. Epub 2021 Apr 1.
3
BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers.BNT162b2信使核糖核酸新冠疫苗在医护人员中的有效性
N Engl J Med. 2021 May 6;384(18):1775-1777. doi: 10.1056/NEJMc2101951. Epub 2021 Mar 23.
4
Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening.新型冠状病毒病 2019（COVID-19）疫苗对接受 COVID-19 分子筛查前无症状感染患者的影响。
Clin Infect Dis. 2022 Jan 7;74(1):59-65. doi: 10.1093/cid/ciab229.
5
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study.202012/1 感染关注的 SARS-CoV-2 变异株的患者的死亡率风险：匹配队列研究。
BMJ. 2021 Mar 9;372:n579. doi: 10.1136/bmj.n579.
6
COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention.COVID-19：对新型冠状病毒疾病的进化、传播、检测、控制和预防的综述。
Viruses. 2021 Jan 29;13(2):202. doi: 10.3390/v13020202.
7
Warnings regarding the potential coronavirus disease 2019 (COVID-19) transmission risk: Vaccination is not enough.关于2019冠状病毒病（COVID-19）潜在传播风险的警告：接种疫苗是不够的。
Infect Control Hosp Epidemiol. 2022 May;43(5):679-680. doi: 10.1017/ice.2021.63. Epub 2021 Feb 10.
8
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
9
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
10
SARS-CoV-2 Vaccination - An Ounce (Actually, Much Less) of Prevention.新型冠状病毒2型疫苗接种——一盎司（实际上远少于此）的预防措施。
N Engl J Med. 2020 Dec 31;383(27):2677-2678. doi: 10.1056/NEJMe2034717. Epub 2020 Dec 10.
Zotero 插件